Shares of Boston Scientific Co. (NYSE:BSX – Get Free Report) have been assigned a consensus rating of “Buy” from the nineteen research firms that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation, seventeen have given a buy recommendation and one has assigned a strong buy […]
Boston Scientific (NYSE:BSX – Get Free Report) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided EPS guidance of 2.230-2.270 for the period, compared to the consensus EPS estimate of 2.240. The company issued revenue guidance of $15.5 billion-$15.6 billion, compared to the consensus revenue estimate of $15.4 billion. […]
Amalgamated Bank grew its stake in Boston Scientific Co. (NYSE:BSX – Free Report) by 1.2% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 375,397 shares of the medical equipment provider’s stock after acquiring an additional 4,485 shares during the quarter. Amalgamated Bank’s holdings […]
Boston Scientific (NYSE:BSX – Get Free Report) posted its quarterly earnings data on Wednesday. The medical equipment provider reported $0.55 earnings per share for the quarter, topping the consensus estimate of $0.51 by $0.04, RTT News reports. The company had revenue of $3.73 billion during the quarter, compared to analysts’ expectations of $3.59 billion. Boston […]
Boston Scientific (NYSE:BSX – Get Free Report) issued its earnings results on Wednesday. The medical equipment provider reported $0.55 EPS for the quarter, beating analysts’ consensus estimates of $0.51 by $0.04, RTT News reports. Boston Scientific had a net margin of 11.19% and a return on equity of 16.19%. The business had revenue of $3.73 […]